BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2292330)

  • 1. Clinical evaluation of tulobuterol aerosol in childhood asthma.
    Sienra-Monge JJ; Graham-Zapata LF; Del Rio-Navarro BE
    J Int Med Res; 1990; 18(6):483-8. PubMed ID: 2292330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of asthma with tulobuterol or albuterol in school-age children.
    Le Bourgeois M; de Blic J; Chauvin JP; Scheinmann P; Paupe J
    Clin Ther; 1990; 12(6):513-9. PubMed ID: 2289220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.
    Patel KR
    Br J Clin Pharmacol; 1986 Feb; 21(2):234-7. PubMed ID: 3513811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a new beta 2-agonist reduce the mortality of asthma?
    Aldons PM
    Lung; 1990; 168 Suppl():186-91. PubMed ID: 1974675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma.
    Patel KR
    Br J Clin Pharmacol; 1985 Dec; 20(6):717-8. PubMed ID: 4092004
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary function tests in asthmatic children in treatment with tulobuterol].
    Pérez-Martini L; Blanco RA; Heffner G; Ordóñez-Comparini R
    Bol Med Hosp Infant Mex; 1989 Apr; 46(4):241-5. PubMed ID: 2719810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
    Lin Q; Liu QH; Bao YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
    Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C
    Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effectiveness of tulobuterol inhaler, a new beta 2-agonist, in the treatment of asthma.
    Charpin D
    Lung; 1990; 168 Suppl():194-201. PubMed ID: 1974677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
    Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children.
    Adler A; Uziel Y; Mei-Zahav M; Horowitz I
    Pulm Pharmacol Ther; 2006; 19(4):281-5. PubMed ID: 16169761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
    Werdermann K
    Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.